scholarly journals Estimating the cost-effectiveness of brief interventions for heavy drinking in primary health care across Europe

2016 ◽  
pp. ckw122 ◽  
Author(s):  
Colin Angus ◽  
Chloe Thomas ◽  
Peter Anderson ◽  
Petra S. Meier ◽  
Alan Brennan
1996 ◽  
Vol 240 (1) ◽  
pp. 23-29 ◽  
Author(s):  
MAGNUS JOHANNESSON ◽  
LARS BORGQUIST ◽  
BENGT JONSSON ◽  
LARS H. LINDHOLM

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Geerke Duijzer ◽  
Andrea J. Bukman ◽  
Aafke Meints-Groenveld ◽  
Annemien Haveman-Nies ◽  
Sophia C. Jansen ◽  
...  

Abstract Background Although evidence is accumulating that lifestyle modification may be cost-effective in patients with prediabetes, information is limited on the cost-effectiveness of interventions implemented in public health and primary health care settings. Evidence from well-conducted pragmatic trials is needed to gain insight into the realistic cost-effectiveness of diabetes prevention interventions in real-world settings. The aim of this study is to assess the cost-effectiveness of the SLIMMER lifestyle intervention targeted at patients at high risk of developing type 2 diabetes compared with usual health care in a primary care setting in the Netherlands. Methods Three hundred and sixteen high-risk subjects were randomly assigned to the SLIMMER lifestyle intervention or to usual health care. Costs and outcome assessments were performed at the end of the intervention (12 months) and six months thereafter (18 months). Costs were assessed from a societal perspective. Patients completed questionnaires to assess health care utilisation, participant out-of-pocket costs, and productivity losses. Quality Adjusted Life Years (QALY) were calculated based on the SF-36 questionnaire. Cost-effectiveness planes and acceptability curves were generated using bootstrap analyses. Results The cost-effectiveness analysis showed that the incremental costs of the SLIMMER lifestyle intervention were €547 and that the incremental effect was 0.02 QALY, resulting in an incremental cost-effectiveness ratio (ICER) of €28,094/QALY. When cost-effectiveness was calculated from a health care perspective, the ICER decreased to €13,605/QALY, with a moderate probability of being cost-effective (56% at a willingness to pay, WTP, of €20,000/QALY and 81% at a WTP of €80,000/QALY). Conclusions The SLIMMER lifestyle intervention to prevent type 2 diabetes had a low to moderate probability of being cost-effective, depending on the perspective taken. Trial registration The SLIMMER study is retrospectively registered with ClinicalTrials.gov (Identifier NCT02094911) since March 19, 2014.


2021 ◽  
Vol 26 (11) ◽  
pp. 5711-5726
Author(s):  
Camila Bosquiero Papini ◽  
Leonardo de Campos ◽  
Priscila Missaki Nakamura ◽  
Bruna Thaís Gomes de Brito ◽  
Eduardo Kokubun

Abstract Physical exercise programs have been carried out in primary health care in Brazil and have provided good results in terms of effectiveness, their economic contribution has not been investigated yet. The aim of the study is to verify the feasibility of brief counseling physical activity intervention and to compare its economic cost and cost-effectiveness with supervised physical exercise intervention in primary care. A multi-arm parallel feasibility trial, with equal randomization [1:1:1] was conducted in Basic Health Units in Brazil. 61 participants were randomized in Brief Counseling Intervention (BCI), Supervised Physical Exercise Intervention (SPEI) and Control Group (CG). Interventions lasted one year. The BCI is more economical than the SPEI, costing around 50% less in the economic comparisons (session cost, annual cost and cost per participant annually). At leisure time, the cost to move one person to the physically active category at 12 months is estimated in R$369.00 for BCI and R$426.21 for the SPEI. The Incremental Cost-effectiveness Ratio (ICER) is R$310.32. The BCI is feasible and more economic, however, the cost effective is not that different. Thus, it is strongly recommended that the two interventions be offered at primary care in Brazil.


2018 ◽  
Vol 2 (4) ◽  
pp. 622-633
Author(s):  
Ayu Pramudita Wardani ◽  
Eri Witcahyo ◽  
Sri Utami

Abstrak Biaya yang dihabiskan untuk penyakit katastropik hingga semester I tahun 2017 telah mencapai Rp 12,7 trilliun atau 24,81% dari total biaya rumah sakit. Jumlah peserta Prolanis Puskesmas Karangduren sebanyak 46 peserta dengan RPPRB sebesar 92,60% dan Patrang sebanyak 45 orang dengan RPPRB sebesar 42,96%. Tujuan penelitian ini adalah menganalisis efektivitas biaya Prolanis pada Puskesmas Karangduren dan Patrang. Jenis penelitian ini adalah deskriptif. Penelitian dilakukan pada bulan September 2017 sampai dengan Oktober 2017. Data diperoleh dengan studi dokumentasi dan wawancara pada penanggung jawab Prolanis, bagian keuangan JKN dan tata usaha. Hasil penelitian menunjukkan input Prolanis pada Puskesmas Karangduren dan Patrang yakni ketersediaan SDM dan dana untuk Prolanis yang tidak keluar, serta kegiatan home visit belum terlaksana karena tidak adanya dana untuk transport petugas dan kurangnya SDM home visit. Hanya peserta Prolanis Puskesmas Patrang dengan riwayat hipertensi telah mencapai indikator 75%. Simpulan penelitian ini adalah efektivitas biaya Prolanis Puskesmas Karangduren lebih efektif dibandingkan Puskesmas Patrang.   Abstract The cost was spent  for catastrophic disease until first semester of 2017 have reached Rp 12.7 trillion or 24.81% of the total cost hospital. The amount participants of Prolanis Karangduren  primary health care was  46 participants with RPPRB of 92.60% and  Patrang was 45 participants  with RPPRB of 42.96%. The purpose of this study was to analyze the cost effectiveness of Prolanis at Karangduren and Patrang primary health care. The study was a  descriptive design. This study was conducted from September until October 2017. Data was collected by documentation and interview of Prolanis officer, finance JKN and administration staff. The results showed Prolanis input on Karangduren and Patrang  primary health care were  the availability of human resources and the fund that do come out,, and home visit activity had not been done yet. Only Prolanis participants of Patrang primary health care with the history of hypertension has reached 75% indicator every month. The cost effectiveness Prolanis Karangduren primary health care more effective was compared to Patrang primary health care.  


2021 ◽  
Author(s):  
Anna Bunova ◽  
Veronika Wiemker ◽  
Boris Gornyi ◽  
Carina Ferreira-Borges ◽  
Maria Neufeld

BACKGROUND Personalized prevention tools, such as mobile applications designed to reduce alcohol consumption, are widespread in mobile application stores accessible in Russia. However, their quality and content have not been systematically evaluated. OBJECTIVE This study aimed to identify Russian-language mobile applications for reducing alcohol use and evaluate their quality and potential to change alcohol-related health behavior. It further aimed to identify applications that could facilitate screening and brief interventions in primary health care in Russia. METHODS A systematic search for mobile applications available in Russia was carried out between April 1 and 15, December 1 and 15, 2020, and in March 2021 in the iOS App Store, Google Play Store, and the 4PDA forum. Application quality was assessed via the Mobile App Rating Scale (MARS), and structured searches in electronic libraries and bibliographic databases used to evaluate the applications’ evidence base. The number of features facilitating changes in lifestyle behavior was assessed using the App Behavior Change Scale (ABACUS). RESULTS We identified a total of 63 mobile applications for reducing alcohol use. Mean MARS quality ratings were high for the subscales of “Functionality” (3.92 out of 5, SD = 0.58) and “Aesthetics” (2.96; SD = 0.76) and low for “Engagement” (2.42; SD = 0.76) and “Information” (1.65, SD = 0.60). Additional searches in electronic libraries and bibliographic databases (Elibrary, Cyberleninka, Google Scholar) yielded no studies involving the identified applications. ABACUS scores ranged from 1 to 15 out of 25, with a mean of 5 (SD = 3.24). Two of the identified applications might be useful for screening and brief interventions in Russian primary health care after improvements in content and scientific testing. CONCLUSIONS Russian-language mobile applications for reducing alcohol use are accessible in the application stores. Many of them are aesthetically pleasing, functional, and easy to use. However, information about scientific trialing or testing is lacking. Most applications contain a low number of features that facilitate changes in lifestyle behavior. Further research should examine the context of Russian-language mobile applications for reducing alcohol use. Our findings underline the need to develop evidence-based applications to mitigate alcohol consumption in Russia and elsewhere. CLINICALTRIAL PROSPERO (CRD42020167458) (review ongoing).


Sign in / Sign up

Export Citation Format

Share Document